Literature DB >> 23334987

Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.

Joerg Latus1, Renate Lehmann, Meike Roesel, Peter Fritz, Niko Braun, Christoph Ulmer, Wolfgang Steurer, Dagmar Biegger, German Ott, Juergen Dippon, M Dominik Alscher, Martin Kimmel.   

Abstract

The presentation of patients with primary hyperparathyroidism is often atypical and ranges from normocalcemic, primary hyperparathyroidism to severe, symptomatic hypercalcemia. G-protein-coupled, calcium-sensing receptor (CaSR), vitamin D receptor (VDR), and fibroblast growth factor receptor (FGFR)/klotho complexes seem to be involved in the development of pHPT. Parathyroid glands from 53 patients with pHPT and normal parathyroid tissue from 7 patients were obtained during parathyroidectomy. Conventional detailed morphological and immunohistochemical analyses of parathyroid glands were performed after dividing each slide in a 3 × 3 array. From morphology, the number of lipocytes was significantly lower in parathyroid tissue glands in the pHPT group (p < 0.001). Protein expressions of klotho, CaSR, and VDR were significantly reduced in the pHPT compared with the control group (p = 0.004, p = 0.007, p < 0.001). No differences were seen between the two groups (p = 0.35) regarding expression of FGFR. Correlations between expression showed significant positively correlations between klotho and CaSR and FGFR and VDR. No correlations between klotho expression and serum calcium levels could be detected (R = -0.13, p = 0.66), but there were positive correlations between expressions of CaSR/serum phosphate and klotho/serum phosphate. Impaired protein expression of CaSR and VDR seem to be involved in the development of pHPT. The role of the FGFR/klotho-axis remains still unclear. Correlations between protein expression of CaSR and serum phosphate and klotho and serum phosphate levels could be detected. Whether these findings give new insights into the pathogenesis of the disease is yet unknown and has to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334987     DOI: 10.1007/s12020-013-9881-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.

Authors:  Ebru Demıralay; Gülüm Altaca; Beyhan Demırhan
Journal:  Turk Patoloji Derg       Date:  2011

2.  Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism.

Authors:  E Lundgren; E Szabo; S Ljunghall; R Bergström; L Holmberg; J Rastad
Journal:  BMJ       Date:  1998-09-26

Review 3.  Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.

Authors:  Leonidas H Duntas; Nikolaos Stathatos
Journal:  Endocrine       Date:  2011-03-26       Impact factor: 3.633

Review 4.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

Review 5.  A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.

Authors:  James M Ruda; Christopher S Hollenbeak; Brendan C Stack
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

6.  The parathyroid is a target organ for FGF23 in rats.

Authors:  Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

Authors:  Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  alpha-Klotho as a regulator of calcium homeostasis.

Authors:  Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

9.  Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

Authors:  Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa
Journal:  Am J Nephrol       Date:  2010-01-06       Impact factor: 3.754

10.  Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.

Authors:  Angela Gurrado; Andrea Marzullo; Germana Lissidini; Agostino Lippolis; Domenico Rubini; Gaetano Lastilla; Mario Testini
Journal:  World J Surg Oncol       Date:  2008-02-21       Impact factor: 2.754

View more
  9 in total

1.  Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Authors:  Jose Luis Perez Castrillón; Gonzalo Díaz-Soto; Olatz Izaola Jauregui; Enrique Romero; Daniel de Luis Román
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

2.  Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism.

Authors:  Xin Li; Yao Lu; Ling Zhang; Aiping Song; Honglei Zhang; Bo Pang; Jun Liu; Xiaoliang Sun; Haoyang Ji; Linping Huang; Meng Yang
Journal:  BMC Endocr Disord       Date:  2022-06-09       Impact factor: 3.263

Review 3.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

4.  Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.

Authors:  Yi Fan; Weiqing Liu; Ruiye Bi; Michael J Densmore; Tadatoshi Sato; Michael Mannstadt; Quan Yuan; Xuedong Zhou; Hannes Olauson; Tobias E Larsson; Hakan R Toka; Martin R Pollak; Edward M Brown; Beate Lanske
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-04       Impact factor: 11.205

5.  Calcium-sensing receptor signaling - How human disease informs biology.

Authors:  Caroline M Gorvin
Journal:  Curr Opin Endocr Metab Res       Date:  2020-07-02

6.  Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy.

Authors:  Chi Su; Lingqiong Meng; Stanley Z Trooskin; Sue A Shapses; Yuling He; Aseel Al-Dayyeni; Xiangbing Wang
Journal:  Endocrine       Date:  2020-07-24       Impact factor: 3.633

7.  Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.

Authors:  Cynthia S Ritter; Sarah Zhang; James Delmez; Jane L Finch; Eduardo Slatopolsky
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

Review 8.  Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism.

Authors:  Zeli Xiang; Ming Wang; Changxiu Miao; Die Jin; Hongyue Wang
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

9.  PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism.

Authors:  Wenhan Chang; Chia-Ling Tu; Frederic G Jean-Alphonse; Amanda Herberger; Zhiqiang Cheng; Jenna Hwong; Hanson Ho; Alfred Li; Dawei Wang; Hongda Liu; Alex D White; Insoo Suh; Wen Shen; Quan-Yang Duh; Elham Khanafshar; Dolores M Shoback; Kunhong Xiao; Jean-Pierre Vilardaga
Journal:  Nat Metab       Date:  2020-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.